30 / 43
•
Introduction
•
Retrospective Data in GEP-NET
•
Efficacy/Safety
•
Randomized trial: NETTER 1
•
PRRT in other situations
•
Pancreatic/Lung NEN
•
Grade 3 NEN
•
Predictors of Response/Outcome
•
Future
•
Conclusions
|
|
30 / 43
30 / 43
•
Introduction
•
Retrospective Data in GEP-NET
•
Efficacy/Safety
•
Randomized trial: NETTER 1
•
PRRT in other situations
•
Pancreatic/Lung NEN
•
Grade 3 NEN
•
Predictors of Response/Outcome
•
Future
•
Conclusions